What is Prime Medicine's investment proceeds?

Prime Medicine (PRME) reported investment proceeds of $50.89M in Q1 2026.

How has Prime Medicine's investment proceeds changed year-over-year?

Prime Medicine's investment proceeds increased by 1596.3% year-over-year, from $3M to $50.89M.

What is the long-term trend for Prime Medicine's investment proceeds?

Over 2 years (2022 to 2024), Prime Medicine's investment proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $93M to $0.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Prime Medicine PRME Investment Proceeds

Investment Proceeds at other companies

CRISPR TherapeuticsCRSP

$175.5K—

Beam TherapeuticsBEAM

$181.29M-16.5%

Sarepta Therapeutics, Inc.SRPT

$38.89M-4.6%

Monopar TherapeuticsMNPR

$35.25M+2,103%

Immix Biopharma, Inc.IMMX

$3M—

PrecigenPGEN

$55.1M+1,105%

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's investment proceeds?: Prime Medicine (PRME) reported investment proceeds of $50.89M in Q1 2026.
How has Prime Medicine's investment proceeds changed year-over-year?: Prime Medicine's investment proceeds increased by 1596.3% year-over-year, from $3M to $50.89M.
What is the long-term trend for Prime Medicine's investment proceeds?: Over 2 years (2022 to 2024), Prime Medicine's investment proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $93M to $0.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.